Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-20-000345
Filing Date
2020-02-24
Accepted
2020-02-24 16:01:53
Documents
2
Group Members
BIHUA CHENCORMORANT ASSET MANAGEMENT, LPCORMORANT GLOBAL HEALTHCARE GP, LLCCORMORANT GLOBAL HEALTHCARE MASTER FUND, LPCORMORANT PRIVATE HEALTHCARE FUND I, LPCORMORANT PRIVATE HEALTHCARE GP, LLC

Document Format Files

Seq Description Document Type Size
1 schedule13g.htm SC 13G 115216
2 exhibit99-1.htm EX-99.1 5383
  Complete submission text file 0000929638-20-000345.txt   122495
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Filed by) CIK: 0001583977 (see all company filings)

EIN.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Subject) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91387 | Film No.: 20644250
SIC: 2836 Biological Products, (No Diagnostic Substances)